Routine share withholding; mechanical by default.
Loading…
Traded Jul 31, 2026 · Filed Aug 4, 2026
Incyte's & Chief Scientific Officer sold $1.75M of Incyte shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,751,403
Shares × reported transaction price
3 days after results of Jul 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $119.52 on Jul 31, 2026, 58% above its 52-week low and 8% below its high, after a 21% rise over the previous 30 trading days
52-week range $75.59 (Aug 1, 2025) to $129.93 (Jul 28, 2026), 81% of the way up, from 251 adjusted closes. 30 trading days earlier: $98.99 on Jun 17, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.8% | +0.3% | +0.5% |
| 30 days | +5.8% | +0.1% | +5.8% |
Past results only. Not a forecast.
Routine share withholding; mechanical by default.
Officer sold ~$1.36M of Incyte
Automatic sale
